when was semaglutide fda approved just got FDA-approved for kidney disease. This changes everything., January 2025. The semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Wegovy Pill FDA Approved: What

Semaglutide (marketed as Wegovy for weight management and Ozempic for diabetes) produced an average 15.8% body weight reduction over 68 weeks in the STEP trials

The NHS is offering semaglutide for only two years, which is how long people can access weight loss clinics

What Recent Human Studies Reveal About Thyroid Safety Recent epidemiologic analyses provide valuable insight into thyroid outcomes among GLP-1 users

You have not changed your caloric intake upward

This is common when weight loss slows down, appetite control is no longer as strong, or a healthcare provider recommends trying a medication with a different mechanism of action

6), future studies examining optimal dose for alcohol reduction are needed